Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
12.63
+0.24 (1.94%)
At close: Nov 20, 2024, 4:00 PM
12.71
+0.08 (0.63%)
After-hours: Nov 20, 2024, 4:44 PM EST
Evolus Market Cap
Evolus has a market cap or net worth of $799.75 million as of November 21, 2024. Its market cap has increased by 73.19% in one year.
Market Cap
799.75M
Enterprise Value
844.59M
1-Year Change
73.19%
Ranking
Category
Stock Price
$12.63
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $799.75M, an increase of 194.76%. That is a compound annual growth rate of 17.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avid Bioservices | 777.70M |
| Cytek Biosciences | 776.73M |
| Cronos Group | 775.61M |
| Erasca | 771.85M |
| Pacira BioSciences | 768.32M |
| Pliant Therapeutics | 749.72M |
| CARGO Therapeutics | 738.75M |
| Replimune Group | 736.86M |